Prognostic Significance of Different Ventricular Ectopic Burdens During Submaximal Exercise in Asymptomatic UK Biobank Subjects.

cardiovascular diseases electrocardiography exercise mortality ventricular premature complexes

Journal

Circulation
ISSN: 1524-4539
Titre abrégé: Circulation
Pays: United States
ID NLM: 0147763

Informations de publication

Date de publication:
12 Dec 2023
Historique:
pubmed: 19 10 2023
medline: 19 10 2023
entrez: 19 10 2023
Statut: ppublish

Résumé

The consequences of exercise-induced premature ventricular contractions (PVCs) in asymptomatic individuals remain unclear. This study aimed to assess the association between PVC burdens during submaximal exercise and major adverse cardiovascular events (MI/HF/LTVA: myocardial infarction [MI], heart failure [HF], and life-threatening ventricular arrhythmia [LTVA]), and all-cause mortality. Additional end points were MI, LTVA, HF, and cardiovascular mortality. A neural network was developed to count PVCs from ECGs recorded during exercise (6 minutes) and recovery (1 minute) in 48 315 asymptomatic participants from UK Biobank. Associations were estimated using multivariable Cox proportional hazard models. Explorative studies were conducted in subgroups with cardiovascular magnetic resonance imaging data (n=6290) and NT-proBNP (N-terminal Pro-B-type natriuretic peptide) levels (n=4607) to examine whether PVC burden was associated with subclinical cardiomyopathy. Mean age was 56.8±8.2 years; 51.1% of the participants were female; and median follow-up was 12.6 years. Low PVC counts during exercise and recovery were both associated with MI/HF/LTVA risk, independently of clinical factors: adjusted hazard ratio (HR), 1.2 (1-5 exercise PVCs, In this cohort of middle-aged and older adults, PVC count during submaximal exercise and recovery were both associated with MI/HF/LTVA, all-cause mortality, HF, LTVAs, and cardiovascular mortality, independent of clinical and exercise test factors, indicating an incremental increase in risk as PVC count rises. Complex PVC rhythms were associated with higher risk compared with PVC count alone. Underlying mechanisms may include the presence of subclinical cardiomyopathy.

Sections du résumé

BACKGROUND UNASSIGNED
The consequences of exercise-induced premature ventricular contractions (PVCs) in asymptomatic individuals remain unclear. This study aimed to assess the association between PVC burdens during submaximal exercise and major adverse cardiovascular events (MI/HF/LTVA: myocardial infarction [MI], heart failure [HF], and life-threatening ventricular arrhythmia [LTVA]), and all-cause mortality. Additional end points were MI, LTVA, HF, and cardiovascular mortality.
METHODS UNASSIGNED
A neural network was developed to count PVCs from ECGs recorded during exercise (6 minutes) and recovery (1 minute) in 48 315 asymptomatic participants from UK Biobank. Associations were estimated using multivariable Cox proportional hazard models. Explorative studies were conducted in subgroups with cardiovascular magnetic resonance imaging data (n=6290) and NT-proBNP (N-terminal Pro-B-type natriuretic peptide) levels (n=4607) to examine whether PVC burden was associated with subclinical cardiomyopathy.
RESULTS UNASSIGNED
Mean age was 56.8±8.2 years; 51.1% of the participants were female; and median follow-up was 12.6 years. Low PVC counts during exercise and recovery were both associated with MI/HF/LTVA risk, independently of clinical factors: adjusted hazard ratio (HR), 1.2 (1-5 exercise PVCs,
CONCLUSIONS UNASSIGNED
In this cohort of middle-aged and older adults, PVC count during submaximal exercise and recovery were both associated with MI/HF/LTVA, all-cause mortality, HF, LTVAs, and cardiovascular mortality, independent of clinical and exercise test factors, indicating an incremental increase in risk as PVC count rises. Complex PVC rhythms were associated with higher risk compared with PVC count alone. Underlying mechanisms may include the presence of subclinical cardiomyopathy.

Identifiants

pubmed: 37855144
doi: 10.1161/CIRCULATIONAHA.123.064633
pmc: PMC10712993
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1932-1944

Références

Sci Rep. 2021 Mar 18;11(1):6357
pubmed: 33737684
J Am Coll Cardiol. 1989 Dec;14(7):1659-65
pubmed: 2479667
Heart Rhythm. 2015 Jan;12(1):78-85
pubmed: 25239428
Arch Intern Med. 2008 Jan 28;168(2):225-34
pubmed: 18227372
Nat Commun. 2018 May 16;9(1):1947
pubmed: 29769521
Am Heart J. 2008 Mar;155(3):500.e1-6
pubmed: 18294486
J Appl Physiol (1985). 1985 Oct;59(4):1033-9
pubmed: 4055584
JAMA. 2003 Sep 24;290(12):1600-7
pubmed: 14506119
Stat Med. 2004 Jan 15;23(1):93-104
pubmed: 14695642
N Engl J Med. 2000 Sep 21;343(12):826-33
pubmed: 10995861
Circulation. 2019 Oct 15;140(16):1318-1330
pubmed: 31554410
J Am Coll Cardiol. 2013 Aug 13;62(7):595-600
pubmed: 23747767
J Am Coll Cardiol. 2021 Dec 7;78(23):2278-2280
pubmed: 34857088
J Am Coll Cardiol. 2004 Aug 18;44(4):820-6
pubmed: 15312865
BMC Med. 2021 Nov 19;19(1):278
pubmed: 34794437
Biol Res Nurs. 2020 Jul;22(3):369-377
pubmed: 32342704
Ann Noninvasive Electrocardiol. 2005 Jan;10(1):47-52
pubmed: 15649237
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
Nature. 2018 Oct;562(7726):203-209
pubmed: 30305743
Circulation. 1977 Dec;56(6):985-9
pubmed: 923068
Heart. 2000 Oct;84(4):365-9
pubmed: 10995401
JAMA. 1984 Feb 3;251(5):630-2
pubmed: 6690837
J Am Coll Cardiol. 1983 Dec;2(6):1060-7
pubmed: 6630778
JACC Cardiovasc Imaging. 2023 Apr;16(4):450-460
pubmed: 36648036
N Engl J Med. 2003 Feb 27;348(9):781-90
pubmed: 12606732
Circulation. 2012 Dec 18;126(25):e354-471
pubmed: 23166211
J Am Coll Cardiol. 2021 Dec 7;78(23):2267-2277
pubmed: 34857087
Br J Gen Pract. 2020 Jan 30;70(691):90-91
pubmed: 32001477
Card Electrophysiol Clin. 2011 Mar 1;3(1):23-45
pubmed: 21892379
Am J Physiol Heart Circ Physiol. 2012 Jun 15;302(12):H2451-63
pubmed: 22467299
Circulation. 2004 May 25;109(20):2417-22
pubmed: 15148273

Auteurs

Stefan van Duijvenboden (S)

Institute of Cardiovascular Science, University College London, United Kingdom (S.v.D., M.O., P.D.L.).
William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom (S.v.D., J.R., N.A., S.E.P., A.T., P.B.M.).
Nuffield Department of Population Health, University of Oxford, United Kingdom (S.v.D., A.D.).

Julia Ramírez (J)

William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom (S.v.D., J.R., N.A., S.E.P., A.T., P.B.M.).
Aragon Institute of Engineering Research, University of Zaragoza, Spain and Centro de Investigación Biomédica en Red - Bioingeniería, Biomateriales y Nanomedicina, Spain (J.R.).

Michele Orini (M)

Institute of Cardiovascular Science, University College London, United Kingdom (S.v.D., M.O., P.D.L.).
Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom (M.O., N.A., S.E.P. P.D.L.).

Nay Aung (N)

William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom (S.v.D., J.R., N.A., S.E.P., A.T., P.B.M.).
Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom (M.O., N.A., S.E.P. P.D.L.).
NIHR Barts Biomedical Research Centre, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom (N.A., S.E.P., A.T., P.B.M.).

Steffen E Petersen (SE)

William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom (S.v.D., J.R., N.A., S.E.P., A.T., P.B.M.).
Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom (M.O., N.A., S.E.P. P.D.L.).
NIHR Barts Biomedical Research Centre, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom (N.A., S.E.P., A.T., P.B.M.).

Aiden Doherty (A)

Nuffield Department of Population Health, University of Oxford, United Kingdom (S.v.D., A.D.).

Andrew Tinker (A)

William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom (S.v.D., J.R., N.A., S.E.P., A.T., P.B.M.).
NIHR Barts Biomedical Research Centre, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom (N.A., S.E.P., A.T., P.B.M.).

Patricia B Munroe (PB)

William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom (S.v.D., J.R., N.A., S.E.P., A.T., P.B.M.).
NIHR Barts Biomedical Research Centre, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom (N.A., S.E.P., A.T., P.B.M.).

Pier D Lambiase (PD)

Institute of Cardiovascular Science, University College London, United Kingdom (S.v.D., M.O., P.D.L.).
Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom (M.O., N.A., S.E.P. P.D.L.).

Classifications MeSH